THE INDIVUMED OMICS HUB
Your clinical portal for multi-omics-based oncology research
The Indivumed Omics Hub is an interface exclusively for members of the Indivumed Global Clinical Network. It provides direct access to curated multi-omics data derived from their patients. Through the portal, we send research-related individual data and cohort data back to the hospitals from which we obtained them.
THREE POWERFUL APPS
The Omics Hub consists of three distinct applications, providing different ways for clinicians to access complete multi-omics patient data quickly and efficiently.
Profiler
Deep dive into individual patient data
Individual patients' multi-omic data is compared to a background cohort of the same disease type derived from the database to provide cancer specific context for patient specific disease characteristics.
Explorer
Get a rapid overview of profiles for relevant genes of interest
Users can select a disease cohort in combination with a specific gene and get an overview of the available clinical and multi-omics information. Links to clinically-relevant data sources enable further detailed investigation.
Analyzer
Gain deep insights into data from defined patient cohorts
Users can fine-tune data-type related analyses and select a cohort of interest. This allows investigation into significantly mutated genes, and systematic or gene specific differential expression that can be analyzed for different omics types.
PERKS AND ADVANTAGES
The Indivumed Omics Hub is our way of igniting your passion for personalized oncology. It keeps your patient data ready for ongoing research and allows you to dive deep into reports for your specific needs, while freeing up time to focus on your patients.
Efficient
The intuitive apps help to investigate your patients' data more productively. Reports can be downloaded as interactive charts, tables, and PDF files.
Comprehensive
Three Web Apps provide all you need: Complete multi-omics patient, clinical and cohort data help to identify signatures and markers.
Exclusive
The Omics Hub has been specifically developed to support Indivumed Therapeutics' clinical partners all over the world.
Case Studies
Patient-specific case study publications derived from the Indivumed Omics Hub showcase unique patient journeys, detailing treatment approaches and challenges faced. They provide valuable insights into personalized treatments and disease understanding.
Yang, X. et al.
A primary luminal/HER2 negative breast cancer
patient with mismatch repair deficiency
Cell Death Discovery 9:365 (2023)
Han, Y. et al.
A BRCA2 germline mutation and high expression
of immune checkpoints in a TNBC patient
Cell Death Discovery 9:370 (2023)
Zhu, M. et al.
Genomic and transcriptomic profiling of
hepatocellularcarcinoma reveals a rare molecular subtype
Discover Oncology 15:10 (2024)
Scimeca, M. et al.
Genetically driven predisposition leads to
an unusually genomic unstable renal cell carcinoma
Discover Oncology 15:80 (2024)
Scimeca, M. et al.
Molecular profiling of a bladder cancer
with very high tumour mutational burden
Cell Death Discovery 10:202 (2024)
Read the case study
Giovannini, S. et al.
A comprehensive molecular characterization
of a claudin-low luminal B breast tumor
Biology Direct 19:66 (2024)
Scimeca, M. et al.
Unveiling the Molecular Profile of a Prostate Carcinoma:
Implications for Personalized Medicine
Concetti, L. et al.
Multi-omic Characterization of CMS1 Colorectal Cancer
with Dampened Immune Response
Get in touch
If you would like to learn more about our Clinical Network, the Omics Hub
or a potential collaboration, please do not hesitate to get in touch.
We look forward to hearing from you.
Call us now at:
+49 40 4133 83 0
Send an E-mail at:
info@indivumed.com